AKBM — Aker Biomarine ASA Income Statement
0.000.00%
Last trade - 00:00
- NOK6.25bn
- NOK10.25bn
- $335.30m
- 46
- 39
- 97
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 246 | 289 | 262 | 277 | 335 |
Cost of Revenue | |||||
Gross Profit | 95.3 | 110 | 88.1 | 115 | 113 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 243 | 282 | 276 | 255 | 330 |
Operating Profit | 2.76 | 7 | -13.7 | 22.1 | 5.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -23.3 | 0.688 | -7.4 | 12.2 | -33.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23.8 | -5.46 | -8.01 | 10 | -8.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -23.8 | -5.46 | -8.01 | 10 | -8.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23.8 | -5.46 | -8.01 | 10 | -9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.171 | 0.154 | -0.044 | 0.156 | -0.192 |
Dividends per Share |